TER Teradyne

Research status: Primary-source verified through Teradyne's Q2 2026 results and 10-Q. Valuation basis: $375.74 close on 21 August 2026.

Teradyne is experiencing an extraordinary AI-led semiconductor-test upcycle. Q2 2026 revenue was $1.329B, +104% YoY; Semiconductor Test contributed $1.122B, Product Test $107M and Robotics $100M. GAAP EPS was $2.38, non-GAAP EPS $2.47. Q3 guidance calls for $1.20–1.30B revenue and $1.85–2.15 non-GAAP EPS, still reflecting robust AI demand.

The investment case is stronger than the label 'robotics' suggests: the current earnings engine is AI compute, memory and test complexity. Robotics remains a smaller optionality sleeve. More test insertions, HBM/DRAM complexity, advanced packaging and power-density requirements can structurally lift test intensity per chip even if unit growth moderates.

At $375.74, however, the stock already discounts substantial AI-test success. PowerFund views TER as a high-quality AI-infrastructure/test bottleneck with robotics optionality, but current valuation requires entry discipline.

Investment case

Teradyne sells automated test equipment used to validate increasingly complex semiconductors and electronic systems. AI accelerators, HBM, advanced packaging and higher power densities increase test time/content per device, creating a structural tailwind independent of pure wafer-volume growth.

> The PowerFund thesis is that AI raises semiconductor test intensity faster than unit growth, allowing Teradyne to sustain higher revenue/margins than prior cycles while Robotics adds a separate long-duration option. The thesis only works from today's valuation if compute/memory strength persists into 2027 and peak margins do not mean-revert abruptly.

Verified operating baseline — Q2 2026

• Revenue: $1.329B, +104% YoY.
• Semiconductor Test: $1.122B.
• Product Test: $107M.
• Robotics: $100M.
• GAAP EPS: $2.38.
• Non-GAAP EPS: $2.47.
• Q3 revenue guide: $1.20–1.30B.
• Q3 non-GAAP EPS guide: $1.85–2.15.

Growth engines

1. AI accelerator / compute test.
2. HBM/DRAM/NAND final test.
3. Advanced packaging/system-level test.
4. Photonics/interconnect test.
5. Robotics through Universal Robots / MiR, still a small portion of current earnings.

KPI ladder

PowerFund valuation scenarios

These are PowerFund estimates, not company guidance.

24 months

• Bear (30%) — $210–260: AI test demand normalizes sharply, memory cycle peaks, margins compress.
• Base (45%) — $360–430: test intensity remains elevated, 2027 grows from a strong base and margins normalize only modestly.
• Bull (25%) — $520–650: AI compute/HBM test content continues compounding and Robotics returns to meaningful growth.

Probability-weighted midpoint is roughly $350–420/share.

60 months

• Bear: $230–300.
• Base: $550–750 if structural test intensity drives a higher earnings floor.
• Bull: $900–1,100+ if AI/advanced-packaging complexity plus robotics create multiple durable growth engines.

• Q3 revenue/EPS above the $1.20–1.30B / $1.85–2.15 guide.
• Sustained record memory-test demand.
• Additional merchant GPU / accelerator qualifications.
• Wafer-fab-equipment investment translating into higher 2027 test demand.
• Advanced packaging and photonics test adoption.
• Robotics returning to >15–20% growth.
• Margin resilience as mix evolves.

• Valuation/crowding: current price embeds an unusually strong test cycle.
• Cyclicality: test demand can fall quickly after capacity/device ramps.
• Customer concentration: large compute/memory customers can create lumpiness.
• Advantest competition: especially strong in leading-edge compute/memory.
• Memory mix: can lower gross margin even as revenue rises.
• Robotics is not current diversification: only a small share of revenue.
• Order visibility: test orders can be cancellable/short-cycle.
• AI-factor concentration: another exposure to the same capex ecosystem.

Warning — freeze additions

• Q3 revenue < $1.20B or non-GAAP EPS < $1.85.
• Gross margin <~58% twice.
• Semiconductor Test <~$950M twice while AI capex remains strong.
• Robotics <~$90M twice.
• Major customer qualification loss.

Reduce

• Q4/2027 revenue trajectory implies <10% growth after the current surge.
• Operating margin falls below ~27% without a temporary mix reason.
• Memory/compute test orders fall faster than industry unit demand.

Invalidate

> Invalidate if AI complexity fails to create a structurally higher test-content floor and Teradyne reverts to a normal cyclical earnings profile while the valuation remains elevated.

Hard invalidators include sustained share loss to Advantest at leading-edge compute/memory or major customer displacement.

Teradyne and Advantest dominate leading-edge semiconductor test. Qualification, installed base and engineering support create switching costs, but customers can dual-source and requalify.

Teradyne's broader portfolio adds Product Test and Robotics, but today the moat is primarily advanced ATE engineering. The key strategic question is whether AI raises industry test intensity enough that both market leaders can sustain structurally higher revenue without destructive share competition.

1. Track Teradyne vs Advantest share by compute, HBM/DRAM and merchant GPU.
2. Normalize segment margins through a full cycle.
3. Identify >10% customers and qualification cadence.
4. Track memory-test revenue and HBM/advanced-packaging exposure.
5. Separate Robotics unit growth, ASP and channel inventory.
6. Define correction-readiness valuation zones; current price requires patience.

Next full review: after Q3 2026 results or a material >20% correction with fundamentals intact.